EUVIMEDEUVIMED entdecken
Crossref

Identification of Novel Target DCTPP1 for Colorectal Cancer Therapy with the Natural Small‐Molecule Inhibitors Regulating Metabolic Reprogramming

Li Feng iD, Xinjia Wang, Xinrui Guo, Liyuan Shi, Shihuang Su, Xinjing Li, Jia Wang, Ninghua Tan, Yi Ma, Zhe Wang iD

Angewandte Chemie International Edition · 2024

DOI: 10.1002/anie.202402543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von Li Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 211198, Nanjing, People's Republi…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Pyrophosphatases, Cell Proliferation, Antineoplastic Agents. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the Fundamental Research Funds for the Central Universities, the ''Double First Class'' University Project of China Pharmaceutical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is one of the most common malignant tumors. Identification of new effective drug targets for CRC and exploration of bioactive small‐molecules are clinically urgent. The human dCTP pyrophosphatase 1 (DCTPP1) is a newly identified pyrophosphatase regulating the cellular nucleotide pool but remains unexplored as potential target for CRC treatment. Here, twelve unprecedented chemical architectures terpene‐nonadride heterodimers ( 1 – 12 ) and their monomers ( 13 – 20 ) were isolated from endophyte Bipolaris victoriae S27. Compounds 1 – 12 represented the first example of terpene‐nonadride heterodimers, in which nonadride monomers of 1 and 2 were also first example of 5/6 bicyclic nonadrides. A series of assays showed that 2 could repress proliferation and induce cell cycle arrest, apoptotic and autophagic CRC cell death in vitro and in vivo. Clinical cancer samples data revealed that DCTPP1 was a novel target associated with poor survival in CRC. DCTPP1 was also identified as a new target protein of 2 . Mechanically, compound 2 bound to DCTPP1, inhibited its enzymatic activity, intervened with amino acid metabolic reprogramming, and exerted anti‐CRC activity. Our study demonstrates that DCTPP1 was a novel potential biomarker and therapeutic target for CRC, and 2 was the first natural anti‐CRC drug candidate targeting DCTPP1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsPyrophosphatasesCell ProliferationAntineoplastic AgentsHumansSmall Molecule LibrariesDrug Screening Assays, AntitumorApoptosisAnimalsEnzyme InhibitorsMiceMolecular StructureCell Line, TumorBiological ProductsMetabolic Reprogramming

Stichwörter der Autor:innen

Bipolaris victoriaeamino acid metabolic reprogramminghuman dCTP pyrophosphatase 1structure elucidationterpene-nonadride heterodimers

Substanzen

PyrophosphatasesAntineoplastic AgentsdCTP pyrophosphataseSmall Molecule LibrariesEnzyme InhibitorsBiological Products

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 211198, Nanjing, People's Republic of China.
  • School of Pharmacy, Nanjing Medical University, 211166, Nanjing, People's Republic of China.
  • State Key Laboratory of Natural Medicines, School of Engineering, China Pharmaceutical University, 211198, Nanjing, People's Republic of China.

ORCID-Profile: Li Feng, Zhe Wang

Förderung

  • the National Natural Science Foundation of China
  • the Fundamental Research Funds for the Central Universities
  • the ''Double First Class'' University Project of China Pharmaceutical University
  • Program for Jiangsu Provincial Excellent Scientific and Technological Innovation Team

Zitieren

APA

Feng, L., Wang, X., Guo, X., Shi, L., Su, S., Li, X., Wang, J., Tan, N., Ma, Y., & Wang, Z. (2024). Identification of Novel Target DCTPP1 for Colorectal Cancer Therapy with the Natural Small‐Molecule Inhibitors Regulating Metabolic Reprogramming. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202402543

Vancouver

Feng L, Wang X, Guo X, Shi L, Su S, Li X, et al. Identification of Novel Target DCTPP1 for Colorectal Cancer Therapy with the Natural Small‐Molecule Inhibitors Regulating Metabolic Reprogramming. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202402543

BibTeX
@article{Feng2024,
  author = {Feng, Li and Wang, Xinjia and Guo, Xinrui and Shi, Liyuan and Su, Shihuang and Li, Xinjing and Wang, Jia and Tan, Ninghua and Ma, Yi and Wang, Zhe},
  title = {Identification of Novel Target DCTPP1 for Colorectal Cancer Therapy with the Natural Small‐Molecule Inhibitors Regulating Metabolic Reprogramming},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  doi = {10.1002/anie.202402543}
}
Kostenlos starten →